Baseline Neuropsychological Characteristics of Adolescents and Young Adults with Down Syndrome Who Participated in Two Clinical Trials of the Drug Memantine
This study demonstrated remarkable consistency of results across studies in two countries with significantly different cultures and levels of socioeconomic development, which provides supporting evidence for the future design and implementation of similar multicenter, international clinical studies involving participants with DS.
Authors
- Richard Boada
- Guilherme Abreu-Silveira
- H. Gerry Taylor (ORCID: https://orcid.org/0000-0001-9035-0853)
- Patrícia Salmona
- Ana Cláudia Brandão (ORCID: https://orcid.org/0000-0002-8034-3980)
- Thomas Scheidemantel (ORCID: https://orcid.org/0000-0002-5465-7871)
- Stephen Ruedrich (ORCID: https://orcid.org/0009-0008-4491-1777)
- Alberto C. S. Costa (ORCID: https://orcid.org/0000-0002-7855-1190)
- Mark W. Johnson
- Nancy Roizen (ORCID: https://orcid.org/0000-0002-5699-9445)
- Veridiana Leiva
Institutions
- Kennedy Krieger Institute (US)
- Nationwide Children's Hospital (US)
- Hospital Israelita Albert Einstein (BR)
- Centro de Estudos e Pesquisas em Educação, Cultura e Ação Comunitária (BR)
- The Ohio State University (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Brain Sciences
- Published
- 2025-10-29
- DOI
- https://doi.org/10.3390/brainsci15111164
- Primary Topic
- Down syndrome and intellectual disability research
- Type
- article
- Field-Weighted Citation Impact
- 0.00